Here is the top health news for today:
Vasopressor Complication Costs Patient Fingers; Hospital, Doctors slapped Rs 6 lakh compensation for negligence
The District Consumer Disputes Redressal Commission, Salem, recently directed a city-based private hospital and its four doctors to pay Rs 6 lakh compensation to a patient who lost three fingers on his right hand while undergoing treatment at the hospital.
Even though the hospital and the doctors claimed that standard treatment using antibiotics fluid, resuscitation, vasopressors and oxygen supplementation was given to the complainant, who was suffering from septic shock, the Consumer Court opined that the doctors should have taken reasonable care in the treatment of the complainant in choosing a method or procedure of treatment.
The court noted that high-dose infusion of vasopressors can induce peripheral vasoconstruction and Vasopressor induced tissue ischemia and gangrene.
For more information, click on the link below:
NMC grants Conditional Approval to Medical Colleges in Chhattisgarh
In a relief to the undergraduate medical education system in Chhattisgarh, the National Medical Commission (NMC) has granted a conditional approval to all state-run government and private medical colleges in the State for the academic session 2025-2026, as reported by the Hitavada.
Earlier, these colleges had received notices from the Apex Medical Commission for failing to meet the essential standards.
Medical Dialogues had earlier reported that, noting critical faculty shortage along with a lack of essential resources, NMC had issued show-cause notices to the government medical colleges in Chhattisgarh. In some cases, the Commission had imposed a monetary penalty.
NMC had reportedly imposed a penalty of Rs 1 crore on Kanker Medical College, Rs 4 lakh fine on Durg Medical College, and Rs 3 lakh fine each in the medical colleges located at Bilaspur, Ambikapur, Mahasamund, and Jagdalpur. Further, the medical colleges in Mahasamund, Kanker, and Raigarh had also received show-cause notices over the shortage of faculty.
For more information, click on the link below:
NMC gives Conditional Approval to Chhattisgarh Medical Colleges
NEET 2025: AIIMS, JIPMER, BHU offer 2,179 MBBS seats- MCC seat matrix
The Medical Counselling Committee (MCC) officially released the final seat matrix for Round 1 of NEET UG 2025 counselling, confirming a total of 2,179 MBBS seats across premier institutions, including 20 AIIMS campuses, JIPMER Puducherry and Karaikal, and the Institute of Medical Sciences, BHU Varanasi.
As per the MCC data, these 2,179 MBBS seats are distributed among top-tier institutions, including AIIMS New Delhi, AIIMS Jodhpur, AIIMS Raipur, AIIMS Rishikesh, and others. This seat matrix is crucial for aspiring medical students participating in Round 1 of NEET UG 2025 counselling.
The leading institutes in terms of MBBS seat availability under NEET UG 2025 include AIIMS Jodhpur with the highest number at 150 seats, followed by JIPMER Puducherry offering 134 seats. Several other prominent AIIMS institutions - AIIMS Deogarh, Kalyani, Nagpur, Patna, Raipur, Rishikesh, and Bhopal - each contribute 125 MBBS seats, making them significant contributors in the overall seat matrix.
For more information, click on the link below:
NEET 2025: AIIMS, JIPMER, BHU offer 2,179 MBBS seats- MCC seat matrix
Gujarat Cancer and Research Institute treats over 4,300 patients in 4 years
The Gujarat Cancer and Research Institute (GCRI) in Ahmedabad has treated 4,397 cancer patients between 2020 and 2024, reinforcing the state's emergence as a national hub for advanced lung cancer treatment.
Of these, 3,256 patients benefited from the PMJAY-MA health scheme, underscoring the state’s commitment to affordable, high-quality cancer care.
Speaking on World Lung Cancer Day, GCRI officials urged the public to prioritise early screening and tobacco cessation, stressing that over 40 per cent of cases in India are diagnosed at late stages, significantly reducing survival chances, news agency IANS reported.
GCRI Director Dr. Shashank Pandya emphasised, “Awareness is our greatest defence. Early detection, quitting tobacco, and timely care can save lives.”
The annual number of patients seeking treatment at GCRI has seen a steady rise: 700 in 2020, 813 in 2021, 865 in 2022, 933 in 2023 and 1,086 in 2024. Among the 4,397 patients treated, 3,597 were men, 799 were women, and one child, with 1,426 patients coming from other Indian states—further validating Gujarat’s growing reputation in cancer care.
For more information, click on the link below:
Gujarat Cancer and Research Institute Treats over 4,300 patients in 4 years, urges early screening
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.